论文部分内容阅读
目的:探讨加味黄连温胆汤联合西药四联疗法治疗幽门螺杆菌相关性胃炎的临床效果。方法:以2013年6月-2015年6月本院收治的86例幽门螺杆菌相关性胃炎患者为研究对象,将其按照住院先后顺序分为研究组与对照组。给予对照组患者西药四联疗法进行治疗,同时给予研究组患者加味黄连温胆汤联合西药四联疗法进行治疗。对比分析两组患者的临床治疗效果。结果:研究组患者治疗总有效率明显高于对照组(P<0.05);研究组患者症状改善总有效率明显高于对照组(P<0.05);研究组患者Hp清除率明显高于对照组(P<0.05)。结论:加味黄连温胆汤联合西药四联疗法治疗幽门螺杆菌相关性胃炎有着较好的临床效果,能改善患者临床症状,提升Hp清除率,值得进行深入研究和推广。
Objective: To investigate the clinical effect of Modified Huanglian Wendan Decoction combined with western medicine quadruple therapy on Helicobacter pylori-associated gastritis. Methods: From June 2013 to June 2015, 86 cases of Helicobacter pylori-associated gastritis admitted to our hospital were enrolled in this study. The patients were divided into study group and control group according to the order of hospitalization. The patients in the control group were treated with quadruple western medicine, and the patients in the study group were treated with Modified Huanglian Wendan Decoction combined with western medicine quadruple therapy. Comparative analysis of two groups of patients with clinical effects. Results: The total effective rate of study group was significantly higher than that of control group (P <0.05). The total effective rate of symptom improvement was significantly higher in study group than that in control group (P <0.05). Hp clearance rate in study group was significantly higher than that in control group (P <0.05). Conclusion: Modified Huanglian Wendan Decoction combined with western medicine quadruple therapy has a good clinical effect in Helicobacter pylori-associated gastritis, which can improve clinical symptoms and improve Hp clearance rate, which deserves further study and promotion.